The next growth opportunity for outpatient GI

The capsule endoscopy market has shown significant growth in recent years due to the increased prevalence of gastrointestinal disorders and the growing preference for non-invasive diagnostic procedures, according to a recent market report.

Advertisement
By: Francesca Mathewes

1. The capsule endoscopy market is projected to grow from $690 million in 2024 to $760 million in 2025, with a compound annual growth rate of 11.14% 

2. By 2029, the market is projected to grow to $1.15 billion by 2029, hitting a CAGR of 10.88% 

3. Expected growth during this period is tied to an increase in the use of telemedicine services and mobile health solutions, a growing preference for outpatient procedures and the demand for early diagnosis. 

How one academic system cut staffing costs + gained systemwide visibility

Recommended Whitepaper

Advertisement

Next Up in GI & Endoscopy

  • GIs sound the alarm on CMS payment changes

    Gastroenterologists are raising concerns about the CMS’ finalized payment policies, according to a joint statement from the American College of…

    By: Patsy Newitt

  • The new frontiers in GI care

    As gastroenterology evolves, leaders are reimagining how to deliver comprehensive, patient-centered care.  Dinesh Madhok, MD, CEO of Jacksonville, Fla.-based Borland…

    By: Patsy Newitt

  • FDA approves 1st IBS-C drug for children 

    The FDA has approved linaclotide (Linzess) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation,…

    By: Patsy Newitt
Advertisement

Comments are closed.